U.S. markets closed
  • S&P 500

    3,719.04
    +71.75 (+1.97%)
     
  • Dow 30

    29,683.74
    +548.75 (+1.88%)
     
  • Nasdaq

    11,051.64
    +222.13 (+2.05%)
     
  • Russell 2000

    1,715.24
    +52.73 (+3.17%)
     
  • Crude Oil

    81.72
    -0.43 (-0.52%)
     
  • Gold

    1,665.90
    -4.10 (-0.25%)
     
  • Silver

    18.84
    -0.04 (-0.21%)
     
  • EUR/USD

    0.9713
    -0.0026 (-0.26%)
     
  • 10-Yr Bond

    3.7050
    -0.2590 (-6.53%)
     
  • GBP/USD

    1.0837
    -0.0048 (-0.44%)
     
  • USD/JPY

    144.3730
    +0.2510 (+0.17%)
     
  • BTC-USD

    19,437.66
    +322.60 (+1.69%)
     
  • CMC Crypto 200

    447.10
    +18.32 (+4.27%)
     
  • FTSE 100

    7,005.39
    +20.80 (+0.30%)
     
  • Nikkei 225

    26,173.98
    -397.89 (-1.50%)
     

Cancer drug developer, Gates Foundation plot next attack on malaria

·3 min read
Cancer drug developer, Gates Foundation plot next attack on malaria

With technology licensed from Stanford, the partners hope to land a preventive drug into clinical trials against malaria by early 2023.